A detailed history of Nixon Peabody Trust CO transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 97,165 shares of RNXT stock, worth $126,314. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97,165
Previous 97,165 -0.0%
Holding current value
$126,314
Previous $109,000 6.42%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.6 - $2.29 $58,299 - $222,507
97,165 New
97,165 $222,000

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $11.8M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Nixon Peabody Trust CO Portfolio

Follow Nixon Peabody Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.